Dianthus Therapeutics grants 87,000 inducement stock options at $106.02 per share
DNTH•Inducement stock options granted to new employees
Dianthus Therapeutics granted inducement equity awards on Aug. 3, 2026 to six newly hired non-executive employees.
- Non-qualified stock options cover 87,000 shares.
- The options carry a 10-year term and an exercise price of $106.02 per share.
- Vesting is 25% at the first anniversary, then monthly installments over the next 36 months.
